In vivo antioxidant and hypolipidemic effect of cardiospermum halicacabum leaf extract in streptozotocin-induced diabetic rats

Journal of Basic and Clinical Physiology and Pharmacology

Volumn 21, Issue 2, 2010, Pages 107-126

  Veeramani, Chinnaveeramani ^a   Pushpavalli, Ganesan ^a   Pugalendi, Kodukkur Viswanathan ^a  

^a ANNAMALAI UNIVERSITY   (India)

Author keywords

antioxidant; Cardiospermum halicacabum; diabetes; oxidative stress; streptozotocin

Indexed keywords

ANTILIPEMIC AGENT; ANTIOXIDANT; PLANT EXTRACT; THIOBARBITURIC ACID REACTIVE SUBSTANCE; ALPHA TOCOPHEROL; ANTIDIABETIC AGENT; APIGENIN; ASCORBIC ACID; CARDIOSPERMUM HALICACABUM EXTRACT; FATTY ACID; GLIBENCLAMIDE; GLUTATHIONE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID HYDROPEROXIDE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LUTEOLIN; PHOSPHOLIPID; STREPTOZOCIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL; CHEMISTRY; DIABETES MELLITUS, EXPERIMENTAL; DRUG EFFECTS; ENZYMOLOGY; ERYTHROCYTE; KIDNEY; LIPID PEROXIDATION; LIVER; MALE; METABOLISM; PATHOLOGY; PLANT LEAF; RAT; SAPINDACEAE; WISTAR RAT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CARDIOSPERMUM HALICACABUM; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFECT; FATTY ACID BLOOD LEVEL; HYPOLIPEMIA; IN VIVO STUDY; LIPID BLOOD LEVEL; MEDICINAL PLANT; NONHUMAN; PHOSPHOLIPID BLOOD LEVEL; PROTEIN BLOOD LEVEL; STREPTOZOCIN DIABETES; TRIACYLGLYCEROL BLOOD LEVEL; VITAMIN BLOOD LEVEL;

ANIMALS; ANTIOXIDANTS; DIABETES MELLITUS, EXPERIMENTAL; ERYTHROCYTES; HYPOLIPIDEMIC AGENTS; KIDNEY; LIPID PEROXIDATION; LIVER; MALE; PLANT EXTRACTS; PLANT LEAVES; RATS; RATS, WISTAR; SAPINDACEAE; THIOBARBITURIC ACID REACTIVE SUBSTANCES; ANTILIPEMIC AGENTS;

EID: 77957002453     PISSN: 07926855     EISSN: 21910286     Source Type: Journal    
DOI: 10.1515/JBCPP.2010.21.2.107     Document Type: Article

References (62)

1. Stamler, J, Vaccaro, O, Neaton, D, Wentworth, D. For the multiple risk factor intervention trial research group. Diabetes, other risk factors and 12-yr cardiovascular mortality for men screened in the multiple risk factor intervention trial. Diabetes Care 1993; 16:434-44.
2. Okutan, H, Ozcelik, N, Yilmaz, HR, Uz, E. Effects of phenethyl ester onlipid peroxidation and antioxidant enzymes in diabetic rat heart. Clin Biochem 2005;38:191-96.
3. Endo, K, Matsumoto, T, Kobayashi, T, Kasuya, Y, Kamata, K. Diabetes related changes in contractile responses of stomach fundus to endothelin-1 in streptozotocin-induced diabetic rats. J Smooth Mus Res 2005;41:35–47.
4. Brown, WV. Lipoprotein disorders in diabetes mellitus. Med Clin North Am 1994; 78:143-61.
5. Jaiprakash, R, Naga Rani, MA, Venkataraman, BV. Effect of felodipine on serum lipid profile in short term streptozotocin diabetes in rats. Ind J Exp Biol 1993;31:283–284.
6. Asha, VV, Pushpangadan, P. Antipyretic activity of Cardiospermum halicacabum. Ind J Exp Biol 1999; 37:411-14.
7. Chopra, RN, Nayar, SL, Chopra, IC. Glossary of Indian medicinal plants (including the supplement). Council of Scientific and Industrial Research, New Delhi, 1986.
8. Duke, J.A., Ayensu, E.S. Medicinal plants of China. Reference Publications, Inc. ISBN-O-917256-20-4 1985.
9. Kumaran, A, Joel Karunkaran, R. Antioxidant activities of the methanol extract of Cardiospermum halicacabum. Plant Food Hum Nutr 2006; 61:1–5.
10. Benedict, SR. The detection and estimation of glucose in urine. J Am Med Assoc 1911;57:1193-6.
11. Trinder, P. Determination of blood glucose using an oxidase peroxidase system with a noncarcinogenic chromogen. Ann Clin Biochem 1969; 6: 24–30.
12. Niehaus, WG, Samuelson, B. Formation of malondialdehyde from phospholipid arachidonate during microsomal lipid peroxidation. Eur J Biochem 1968; 6:126-30.
13. Jiang, ZY, Hunt, JV, Wolff, SP. Detection of lipid hydroperoxides using the ‘fox method’. Anal Biochem 1992; 202:384-9.
14. Kakkar, P, Das, B, Viswanathan, PN. A modified spectrophotometric assay of superoxide dismutase. Ind J Biochem Biophys 1984; 21:130-2.
15. Sinha, KA. Colorimetric assay of catalase. Anal Biochem 1972; 47: 389-94.
16. Rotruck, JJ, Pope, AL, Ganther, HE, Swanson, AB. Selenium: Biochemical rates as a component of glutathione peroxidase. Science 1973; 179: 588-90.
17. Ellman, GL. Tissue sulphydryl groups. Arch Biochem Biophys 1959; 82: 70-7.
18. Roe, JH, Kuether, CA. Detection of ascorbic acid in whole blood and urine through 2,4-DNPH derivative of dehydroascorbic acid. J Biol Chem 1943; 47: 399-407.
19. Baker, H, Frank, O, De Angelis, B, Feingold, S. Plasma tocopherol in man at various times after ingesting free or acetylated tocopherol. Nutr Rep Int 1980; 21: 531-6.
20. Allain, EC, Poon, LS, Chan, CS, Richmond, W, Fu, FC. Enzymatic determination of total serum cholesterol. Clin Chem 1974; 20: 470-5.
21. Izzo, C, Grillo, F, Murador, E. Improved method for the determination of high density lipoprotein cholesterol. Clin Chem 1981; 27:371-4.
22. Friedwald, WT, Levy, RJ, Fredricken, DS. Estimation of HDL-C in the plasma without use of preparative ultra centrifuge. Clin Chem 1972; 18:449.
23. Foster, LB, Dunn, RT. Stable reagents for determination of serum triglycerides by a colorimetric Hantazsch condensation method. Clin Chim Acta 1973; 19: 338-40.
24. Hron, WT, Menahan, LA. A sensitive method for the determination of free fatty acids in plasma. J Lipid Res 1981; 22: 377-81.
25. Zilversmit, DB, Davis, AK. Micro-determination of plasma phospholipids by trichloroacetic acid precipitation. J Lab Clin Med 1950; 35: 155-9.
26. Feillet, CC, Rock, E, Coudray, C, Grzelkowska, K, Azais, BV, Dardevet, D. Lipid peroxidation and antioxidant status in experimental diabetes. Clin Chim Acta 1999; 284:31–48.
27. Ivorra, MD, Paya, M, Villar, A. A review of natural products and plants as potential antidiabetic drugs. J Ethnopharmacol 1989; 27:243-75.
28. Maritim, AC, Sanders, RA, Watkins, JB. Diabetes, oxidative stress and antioxidants. J Biochem Mol Toxic 2003; 17:24–38.
29. Stringer, MD, Gorgo, PG, Freeman, A, Kakkar, VV. Lipid peroxides and atherosclerosis. Brazilian Med J 1989; 298:281-4.
30. Kumaran, A, Joel Karunkaran, R. Antioxidant activities of the methanol extract of Cardiospermum halicacabum. Plant Food Hum Nutr 2006; 61: 1–5.
31. The European Agency for the Evaluation of Medicinal Products. Veterinary medicines evaluation unit. EMEA/MRL/664/99-FINAL 1999.
32. Bors, W, Hller, W, Michel, C, Saran, M. Flavonoids as antioxidants: determination of radical-scavenging efficiencies. Method Enzymol 1990; 186; 343-55.
33. Nakayama, T, Yamad, M, Oshka, T, Kawakishi, S. Suppression of active oxygen-induced cytotoxicity by fiavonoids. Biochem Pharmacol 1993; 45; 265-73.
34. Niskanen, IK, Salonen, JT, Nyyssonen, K, Visitupa, MU. Plasma lipid peroxidation and hyperglycemia; a connection through hyperinsulinemia? Diabetic Med 1995; 12; 802-8.
35. Nourooz-Zadeh, J, Rahimi, A, Tajaddomo-Sarmadi, J, Tritschler, H, Rosen, P, Halliwell, B. Relationships between plasma measures of oxidative stress and metabolic control in NIDDM. Diabetologia 1997; 40; 647-53.
36. Wohaieb, SA, Godin, DV. Alterations in free radical tissue defense mechanisms in streptozotocin induced diabetes in rats. Diabetes 1987; 36; 1014-18.
37. Jacob, RA. The integrated antioxidant system. Nutr Res 1995; 15; 755-66.
38. Kono, Y, Fridovich, I. Superoxide radicals inhibit catalase. J Biol Chem 1982; 257; 5751-4.
39. Blun, J, Fridovich, I. Inactivation of glutathione peroxidase by superoxide radicals Arch Biochem Biophys 1985; 240; 500-8.
40. Andallu, B, Varadacharyalu, NCI. Antioxidant role of mulberry (Morus indica L.) leaves in streptozotocin diabetic rats. Clin Chim Acta 2003; 338; 3–10.
41. Santhakumari, P, Prakasam, A, Pugalendi, KV. Modulation of oxidative stress parameters by treatment with Piper betle leaf in streptozotocin induced diabetic rats. Indian J Pharmacol 2003; 35; 373-8.
42. Townrend, DM, Tew, KD, Tapiero, H. The importance of glutathione in human disease. Biomed Pharamcother 2003; 57; 145-55.
43. Hodgson, EK, Fridovich, I. The interaction of bovine erythrocyte superoxide dismutase with hydrogen peroxide. Chemiluminescence and peroxidation. Biochem J 1975; 14; 5299–5303.
44. Liu, RH. Potential synergy of phytochemicals in cancer prevention: mechanism of action. J Nutr 2004; 134: 34793-855.
45. Frie, B, England, L, Ames, BN. Ascorbate is an outstanding antioxidant in human blood plasma. Proc Natl Acad Sci (USA) 1989; 86: 6377-81.
46. Packer, L, Tritschler, HJ, Wessel, K. Neuroprotection by metabolic antioxidant alpha lipoic acid. Free Radical Bio Med 1997; 22; 359-78.
47. Freisieben, HJ, Packer, L. Free radical scavenging activities, interactions and recycling of antioxidants. Biochem Soc Trans 1993;21; 325-30.
48. Stahl, W, Sies, H. Antioxidant defense vitamin E and carotenoids. Diabetes 1997; 46: 14–18.
49. Jain, SK, Levine, SN. Elevated lipid peroxidation and vitamin E quinone levels in heart ventricles of streptozotocin treated diabetic rats. Free Radical Bio Med 1995; 18; 337-41.
50. Yu, BP. Cellular defense against damage from reactive oxygen species. Physiol Rev 1994; 74: 139-62.
51. Lu, SC. Regulation of hepatic glutathione synthesis: current concepts and controversies. FASEB J 1999; 13:1169-83.
52. Nicotera, P, Orrenius, S. Role of thiols in protection against biological reactive intermediates. Adv Exp Med Biol 1986; 197: 41–51.
53. Jain, SK. Glutathione and glucose-6-phosphate dehydrogenase deficiency can increase protein glycation. Free Radical Bio Med 1998; 24: 197–201.
54. Ahmed, RA, Seth, V, Banerjee, BD. Influence of dietary ginger (Zingiber officinalis) on antioxidant defense system in rat: comparison with ascorbic acid. Indian J Exp Biol 2000; 38: 604-6.
55. Davidson, MB. Autoregulation by glucose of hepatic glucose balance, permissive effects of insulin. Metabolism 1981; 30: 279-84.
56. thedition McMillan Publication, New York, 1985;1490–1510.
57. Krishnakumar, K, Augusti, KT, Vijayammal, PL. Hypoglycemic and antioxidant activity of Salacia oblonga Wall, extract in streptozotocin diabetic rats. Indian J Physiol Pharmacol 1999; 43: 510-4.
58. Parving, HH, Hommel, E. Prognosis in diabetic nephropathy. BMJ 1989; 299: 230-3.
59. Arvind, K, Pradeepa, R, Deepa, R, Mohan, N. Diabetes and coronary artery disease. Indian J Med Res 2002; 116:163-76.
60. Draznin, B, Eckel, RH. Diabetes and atherosclerosis. Mol Basis Clin Asp 1993; 12: 203.
61. Frayn, KN. Insulin resistance and lipid metabolism. Curr Opin Lipidol 1993; 4: 197–204.
62. Steinberg, D, Parthasarathy, S, Carew, TE, Khoo, JC, Witztum, JL. Beyond cholesterol, modifications of low-density lipoprotein that increase its atherogenicity. Engl J Med 1989; 320: 915-24.